Ketanserin and captopril interaction in the treatment of essential hypertensives

Cardiovascular Drugs and Therapy

Volumn 4, Issue 1, 1990, Pages 119-122

  Lavezzaro, Giancarlo ^a   Ladetto, Pier Emilio ^a   Valente, Marco ^a   Stramignoni, Daniela ^a   Zanna, Claudio ^b   Assogna, Giuseppe ^b   Salvetti, Antonio ^c  

^a Department of Neurology   (Italy)

^b Janssen Farmaceutici SpA ^*  (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

hypertension; ketanserin captopril interaction; serotonin

Indexed keywords

CAPTOPRIL; KETANSERIN;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOM SAMPLING;

ADULT; ALDOSTERONE; BLOOD PRESSURE; BODY WEIGHT; CAPTOPRIL; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HUMAN; HYPERTENSION; KETANSERIN; MALE; MIDDLE AGE; POTASSIUM; SODIUM;

EID: 0025216618     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/BF00053442     Document Type: Article

References (6)

1. Serotonergic mechanisms in hypertension. Focus on the effects of ketanserin
2. Ketanserin — a new antihypertensive agent
3. Ketanserin versus metoprolol and hydrochlorothiazide in essential hypertension: Only ketanserin's hypertensive effect is age-related
4. Comparison of ketanserin with captopril in older hypertensives: A double-blind randomized trial
5. Angiotensin-converting enzyme inhibitors in the treatment of mild to moderate essential hypertension
6. Ketanserin: A novel cardiovascular drug